Filing Details
- Accession Number:
- 0001209191-16-112563
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-04 18:53:27
- Reporting Period:
- 2016-04-01
- Filing Date:
- 2016-04-04
- Accepted Time:
- 2016-04-04 18:53:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182657 | Md H Frank Valone | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-01 | 10,750 | $3.93 | 115,434 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-01 | 10,550 | $21.10 | 104,884 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-04-01 | 200 | $21.47 | 104,684 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-04-01 | 10,750 | $0.00 | 10,750 | $3.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,722 | 2019-08-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,000 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices between $20.47 and $21.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
